Spotlight on Atomoxetine in Adults with Attention-Deficit Hyperactivity Disorder1
Authors:
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in CNS Drugs
- Vol. 18 (6) , 397-401
Abstract
Atomoxetine (Strattera™) is a selective noradrenaline (norepinephrine) reuptake inhibitor and nonstimulant that has shown greater efficacy than placebo in attention-deficit hyperactivity disorder...Keywords
This publication has 15 references indexed in Scilit:
- Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolitesClinical Pharmacology & Therapeutics, 2003
- Neurotransmission of Cognition, Part 2: Selective NRIs Are Smart Drugs: Exploiting Regionally Selective Actionson Both Dopamine and Norepinephrineto Enhance CognitionThe Journal of Clinical Psychiatry, 2003
- Atomoxetine in adults with ADHD: two randomized, placebo-controlled studiesBiological Psychiatry, 2003
- Cardiovascular Effects of Atomoxetine in Children, Adolescents, and AdultsDrug Safety, 2003
- Comparison of (R)-[3H] Tomoxetine and (R/S)-[3H] Nisoxetine Binding in Rat BrainJournal of Neurochemistry, 2002
- Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity DisorderNeuropsychopharmacology, 2002
- Effect of Potent CYP2D6 Inhibition by Paroxetine on Atomoxetine PharmacokineticsThe Journal of Clinical Pharmacology, 2002
- Binding of antidepressants to human brain receptors: focus on newer generation compoundsPsychopharmacology, 1994
- Localization of rat brain binding sites for [3H]tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sitesNeuroscience Letters, 1993
- Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomesLife Sciences, 1993